Breaking News, Trials & Filings

Pfizer, BioNTech Win First Authorization for COVID-19 Vax

MHRA authorizes supply of BNT162b2 vaccine for emergency supply; companies are ready to deliver the first doses to the U.K. immediately.

By: Contract Pharma

Contract Pharma Staff

Pfizer and BioNTech were granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine BNT162b2 by the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. This is the first Emergency Use Authorization following a worldwide Phase 3 trial of a vaccine to help fight the pandemic. The companies anticipate further regulatory decisions in the coming days and weeks and are ready to deliver vaccine doses following potential regulatory authorizations. The MH...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters